Manufacturers Life Insurance Company, The Applied Therapeutics Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 123,725 shares of APLT stock, worth $108,878. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,725
Previous 36,824
235.99%
Holding current value
$108,878
Previous $171,000
514.62%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$9.28 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$8.72 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$8.65 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$7.04 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$5.98 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $42.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...